[go: up one dir, main page]

AR030537A1 - ANTIBACTERIAL CHINOLINCARBOXILIC AND NAFTIRIDINCARBOXILIC ACIDS - Google Patents

ANTIBACTERIAL CHINOLINCARBOXILIC AND NAFTIRIDINCARBOXILIC ACIDS

Info

Publication number
AR030537A1
AR030537A1 ARP000105819A ARP000105819A AR030537A1 AR 030537 A1 AR030537 A1 AR 030537A1 AR P000105819 A ARP000105819 A AR P000105819A AR P000105819 A ARP000105819 A AR P000105819A AR 030537 A1 AR030537 A1 AR 030537A1
Authority
AR
Argentina
Prior art keywords
antibacterial
naftiridincarboxilic
chinolincarboxilic
acids
prodrugs
Prior art date
Application number
ARP000105819A
Other languages
Spanish (es)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of AR030537A1 publication Critical patent/AR030537A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Los compuestos que tienen la formula (1) o sus prodrogas o sales aceptables para uso farmacéutico son utiles como agentes antibacterianos.The compounds having the formula (1) or its prodrugs or salts acceptable for pharmaceutical use are useful as antibacterial agents.

ARP000105819A 1999-11-05 2000-11-03 ANTIBACTERIAL CHINOLINCARBOXILIC AND NAFTIRIDINCARBOXILIC ACIDS AR030537A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43529799A 1999-11-05 1999-11-05
US70533200A 2000-11-03 2000-11-03

Publications (1)

Publication Number Publication Date
AR030537A1 true AR030537A1 (en) 2003-08-27

Family

ID=27030507

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000105819A AR030537A1 (en) 1999-11-05 2000-11-03 ANTIBACTERIAL CHINOLINCARBOXILIC AND NAFTIRIDINCARBOXILIC ACIDS

Country Status (12)

Country Link
EP (1) EP1226146A2 (en)
JP (1) JP2003524633A (en)
AR (1) AR030537A1 (en)
AU (1) AU1468901A (en)
BG (1) BG106679A (en)
BR (1) BR0010728A (en)
CZ (1) CZ20021531A3 (en)
HK (1) HK1047287A1 (en)
IL (1) IL148738A0 (en)
MX (1) MXPA02004474A (en)
NO (1) NO20022156L (en)
WO (1) WO2001032655A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001286852A1 (en) * 2000-08-29 2002-03-13 Chiron Corporation Quinoline antibacterial compounds and methods of use thereof
JP2004528356A (en) 2001-04-27 2004-09-16 ザ プロクター アンド ギャンブル カンパニー Compounds, compositions and methods for controlling biofilms
US8163769B2 (en) 2002-03-12 2012-04-24 Abbott Laboratories Antibacterial compounds
EP1631570A1 (en) * 2003-03-12 2006-03-08 Abbott Laboratories Naphthyridine derivatives as antibacterial agents
EP1829869A1 (en) * 2006-03-02 2007-09-05 Laboratorios Del Dr. Esteve, S.A. 4,5,6,7-Tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
US20080139574A1 (en) 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
TWI498115B (en) * 2007-12-27 2015-09-01 Daiichi Sankyo Co Ltd Imidazole carbonyl compound
WO2011069063A2 (en) 2009-12-04 2011-06-09 Sunovion Pharmaceuticals, Inc. Multicyclic compounds and methods of use thereof
KR102811121B1 (en) 2016-07-29 2025-05-22 스미토모 파마 아메리카, 인크. Compounds and compositions and their uses
EP3490607A4 (en) 2016-07-29 2020-04-08 Sunovion Pharmaceuticals Inc. COMPOUNDS AND COMPOSITIONS, AND USES THEREOF
IL303177A (en) 2017-02-16 2023-07-01 Sunovion Pharmaceuticals Inc Treatment of schizophrenia
KR20200036008A (en) 2017-08-02 2020-04-06 선오비온 파마슈티컬스 인코포레이티드 Isocroman compounds and uses thereof
JP7453148B2 (en) 2018-02-16 2024-03-19 サノビオン ファーマシューティカルズ インク Salts, crystalline forms, and their production methods
AU2020236225B2 (en) 2019-03-14 2025-12-18 Sumitomo Pharma America, Inc. Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof
JP7781768B2 (en) 2020-04-14 2025-12-08 スミトモ・ファーマ・アメリカ・インコーポレイテッド Methods for treating neurological and psychiatric disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents

Also Published As

Publication number Publication date
IL148738A0 (en) 2002-09-12
BR0010728A (en) 2004-02-17
HK1047287A1 (en) 2003-02-14
NO20022156D0 (en) 2002-05-06
MXPA02004474A (en) 2002-11-07
BG106679A (en) 2003-01-31
JP2003524633A (en) 2003-08-19
NO20022156L (en) 2002-07-04
EP1226146A2 (en) 2002-07-31
CZ20021531A3 (en) 2002-09-11
WO2001032655A3 (en) 2002-01-24
AU1468901A (en) 2001-05-14
WO2001032655A2 (en) 2001-05-10

Similar Documents

Publication Publication Date Title
ECSP034774A (en) PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS
ECSP034773A (en) PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS
AR030537A1 (en) ANTIBACTERIAL CHINOLINCARBOXILIC AND NAFTIRIDINCARBOXILIC ACIDS
ECSP055747A (en) CGRP ANTAGONISTS ELECTED, PROCEDURE FOR PREPARATION, AS WELL AS ITS EMPLOYMENT AS MEDICATIONS
UY28040A1 (en) CGRP ANTAGONISTS ELECTED, PROCEDURE FOR PREPARATION, AS WELL AS ITS EMPLOYMENT AS MEDICATIONS.
CO5271715A1 (en) 7-AZA-INDOLIN-2-WAVES SUBSTITUTED IN 4 AND ITS USE AS PROTEIUNA QUINASA INHIBITORS
ECSP045004A (en) INHIBITORS OF THE 17BETA-HYDROXIESTEROID DEHYDROGENASE TYPE 3 FOR THE TREATMENT OF DEPENDING ANDROGEN DISEASES
ES2193508T3 (en) FTALIZINONES.
AR029766A1 (en) QUINASE INHIBITOR COMPOUND AND USE OF IT TO PREPARE A PHARMACEUTICAL COMPOSITION
PA8468401A1 (en) COMPOUNDS FOR THE TREATMENT OF ISCHEMIA
NO20002173D0 (en) Pleuromutilin derivatives as antimicrobial agents
AR077414A2 (en) PIPERAZINE COMPOUNDS AS TAQUININE ANTAGONISTS ITS SALTS AND SOLVATES PHARMACEUTICAL COMPOSITIONS CONTAINING THEIR USE AND PROCESSES FOR THEIR PREPARATION
AR035284A1 (en) FORMULATIONS IN COMBINATION OF PROPANOL-AMINA DERIVATIVES SUBSTITUTED WITH ARILO, TOGETHER WITH OTHER ACTIVE SUBSTANCES AND ITS USE
ES2421948T3 (en) Compounds and compositions for delivering active agents
NO940144L (en) 2- (4-hydroxypiperidino) 1-alkanol derivatives as anti-chemical agents
AR021843A1 (en) DERIVATIVES OF PROPANOLAMINE SUBSTITUTED WITH HETEROCICLES, PROCEDURE FOR THEIR PREPARATION, AND ITS USE.
HN2002000110A (en) USE OF (Z) - 2 - CIANO - 3 - HYDROXY - BUTIL - 2 - ENOIC ACID (4 '- TRIFLUOROMETIL PHENYL) - AMIDA FOR THE TREATMENT OF MULTIPLE SCLEROSIS.
AR018162A1 (en) SUBSTITUTED PIRROLS, PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE PREPARATION OF SUCH PHARMACEUTICAL COMPOSITION
ES2135722T3 (en) 1,5-BENZODIACEPINES 5-HETEROCICLICAS MODULADORAS DE LA CCK OR DEL GASTRINA.
ECSP034813A (en) ARILSULFONAMIDS AS ANTIVIRAL AGENTS
AR020563A1 (en) TIA-ALQUINOIC COMPOUNDS (POLI) AND THEIR DERIVATIVES, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE
PA8466101A1 (en) THERAPEUTIC AGENTS
AR025379A1 (en) 9A-AZALIDAS WITH ANTIBACTERIAL ACTIVITY.
MX9300306A (en) BENZMIDAZOLES MEDICINES CONTAINING THESE COMPOUNDS AND PROCEDURE FOR THEIR PREPARATION.
MX9700854A (en) DERIVATIVES OF AZABICICLOHEPTANO N-SUBSTITUTED USEFUL AS NEUROLEPTICOS.

Legal Events

Date Code Title Description
FB Suspension of granting procedure